The actual controller of Yatai Pharm will change to Qiu Zhongxun, and trading will resume on October 14
Yatai Pharm announced that its controlling shareholder will change to Zhejiang Xinghao Holdings, and the actual controller will change to Qiu Zhongxun. The company plans to issue no more than 137 million shares to specific targets, with an issue price of 5.11 yuan per share, raising a total of no more than 700 million yuan, all of which will be used for new drug research and development. The stock will resume trading on October 14, 2025
According to the Zhitong Finance APP, Yatai Pharm (002370.SZ) disclosed a plan to issue shares to specific targets for the year 2025. The company intends to issue no more than 137 million shares (including the number) to Zhejiang Xinghao Holding Partnership (Limited Partnership) at an issuance price of 5.11 yuan per share. The total amount of funds raised from this issuance will not exceed 700 million yuan (including the number), and all funds will be used for new drug research and development projects after deducting related issuance expenses.
On October 13, 2025, Xinghao Holding signed a conditional share subscription agreement with the listed company. At the same time, the controlling shareholder of the listed company, Fubon Group, and its wholly-owned subsidiary, Hangu Investment, signed a share transfer agreement with Xinghao Holding and its concerted party, Xingchen Investment; Xinghao Holding and its concerted party, Xingchen Investment, signed a concerted action agreement and a voting rights entrustment agreement. Fubon Group and its wholly-owned subsidiary, Hangu Investment, will transfer a total of 109 million shares of the listed company (accounting for 14.61% of the company's total share capital) to Xinghao Holding and its concerted party, Xingchen Investment, through a negotiated transfer. After the transfer of the above shares, Xingchen Investment will act in concert with Xinghao Holding according to the concerted action agreement to ensure that Xinghao Holding has actual control over Yatai Pharm; Xingchen Investment will unconditionally and irrevocably entrust all voting rights, convening rights, nomination and proposal rights, attendance rights, supervisory and advisory rights, and other rights except for property rights such as income rights and share transfer rights corresponding to the 48.4203 million shares of the listed company (accounting for 6.49% of the company's total share capital) to Xinghao Holding for exercise. The controlling shareholder of the listed company will change to Xinghao Holding, and the actual controller will change to Mr. Qiu Zhongxun.
In addition, the company's stock will resume trading from October 14, 2025
